Neuralink

Neuralink is developing an implantable brain-computer interface (BCI) system that records neural signals from the brain and translates them into digital commands for controlling external devices. The implanted chip, called N1, is placed in the motor cortex region of the brain by a precision surgical robot and communicates wirelessly with external software. Early clinical trial participants have demonstrated the ability to control a computer cursor, type text, and interact with software applications using neural signals alone, without any physical movement required. The system is designed to function continuously and recharge wirelessly without external connections. Explore this option. Neuralink's current clinical work is focused on individuals with quadriplegia, ALS, and other conditions causing severe motor impairment who have no functional use of their limbs and cannot communicate or interact with technology through standard input methods. The PRIME Study, which received FDA Breakthrough Device designation, is evaluating the safety and initial efficacy of the N1 device in this patient population. Participants in the trial use the BCI to control computers for communication, web browsing, and digital productivity. Neuralink's longer-term research roadmap includes restoring vision through a separate device called Blindsight and expanding the range of conditions the technology addresses Browse related picks.